| abstract |
The present invention relates to a suspension formulation containing the active substance 3-Z- [1- (4- (N - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl-2-indolinone-monoethanesulfonate, to a pharmaceutical capsule dosage form containing said suspension formulation, to a procedure for preparing said suspension formulation, to a procedure for preparing said capsule comprising said suspension formulation and the packaging material for the finished capsule. |